Table 2.
Type 2 Diabetes (T2D) with subcategorisation.
| T2D | Controls | |
|---|---|---|
| Total number of patients | 29,700 (100%) | 119,951 (100%) |
| Mean age 95% Confidence Interval (CI)) in years | 65 (63.9–66.1) | 64.6 (64.0–65.2) |
| With Long COVID diagnosis | 115 (0.39%) | 446 (0.37%) |
| With Diagnosis and/or Referral | 156 (0.53%) | 647 (0.54%) |
| Sex | ||
| Male | 15,469 (52.5%) | 57,938 (48.3%) |
| Male with Long COVID | 83 (0.54%) | 267 (0.46%) |
| Female | 13,769 (47.4%) | 62,013 (51.7%) |
| Female with Long COVID | 73 (0.53%) | 380 (0.61%) |
| BMI | ||
| BMI ≥ 30 | 13,342 (44.9%) | 18,617 (15.5%) |
| BMI ≥ 30 with Long COVID | 77 (0.58%) | 137 (0.74%) |
| BMI < 30 | 10,641 (35.8%) | 36,229 (30.2%) |
| BMI < 30 with Long COVID | 55 (0.52%) | 211 (0.58%) |
| Unknown BMI | 5717 (19.3%) | 65,105 (54.3%) |
| Unknown BMI with Long COVID | 24 (0.42%) | 299 (0.46%) |
| Ethnicity | ||
| White | 20,892 (70.3%) | 96,751 (80.7%) |
| White + Long COVID | 117 (0.56%) | 550 (0.57%) |
| Black | 911 (3.07%) | 1940 (1.62%) |
| Black + Long COVID | <10 | <10 |
| Asian | 5171 (17.4%) | 6898 (5.75%) |
| Asian + Long COVID | 20 (0.39%) | 41 (0.59%) |
| Mixed | 278 (0.94%) | 952 (0.79%) |
| Mixed + Long COVID | <10 | <10 |
| Other | 1901 (6.4%) | 10,284 (8.57%) |
| Other + Long COVID | <10 | 29 (0.28%) |
| Unknown | 547 (1.84%) | 3126 (2.61%) |
| Unknown + Long COVID | <10 | 13 (0.42%) |
Long COVID % refers to the proportion within each category. For example, for men with T2D, the denominator is 15,469 and for T2D controls with BMI ≥ 30 the denominator is 18,617.